Российское общество по изучению печени.Рекомендации по диагностике и лечению взрослых больных гепатитом С.2014

http://www.clinicaloptions.com/inPractice/Hepatology/Hepatology/ch8_Mgmt_ of_Hep_C_Infection.aspx

41.Manns MP, Wedemeyer H, Singer A, Khomutjanskaja N, Dienes HP, Roskams T, Goldin R, Hehnke U, Inoue H; the European SNMC Study GroupGlycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks.J Viral Hepat. 2012 Aug;19(8):537-546. doi: 10.1111/j.1365-2893.2011.01579.x. Epub 2012 Feb 24.

42.Sarrazin C, Christophe Hezode Ch, Zeuzem S, Jean-Michel Pawlotsky J-M Antiviral strategies in hepatitis C virus infection Journal of Hepatology 2012, S88–S100

43.Sherman KE, et al. Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med 2011;365:1014–24. Erratum in: N Engl J Med 2011;365:1551.

44.Zarski J.P., Sturm N., Guechot J. et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol. 2012 Jan;56(1):55-62.

45.Zeuzem S et al. Telaprevir for Retreatment of HCV Infection. N Engl J Med

2011;364:241728.

91